🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

A shout out 2 the entire #myeloma faculty UCSF Helen Diller Family Comprehensive Cancer Ctr Your presentations were informative & your detailed answers during Q&A were appreciated I forgot to take a picture of entire group, but a captured a few smiling faces. HealthTree Foundation RoundTable #mmsm Ajai Chari Alfred Chung

Yelak Biru International Myeloma Foundation “Support groups are family” My favorite there 🙂

A 'Whole Different Ballgame' for Myeloma Treatment curetoday.com/view/a-whole-d… via Cure

For newly diagnosed frail pts, check out a new Ph3 trial S2209 comparing different induction and maintenance regimens. Revealing the Correlation Between Multiple #Myeloma and Frailty: Contemporary Perspectives and In... - goo.gl/scholar/9sPFBB #ScholarAlerts

Great news for #myeloma patients! Happy to see my friends @MyelomaTeacher - Cindy Chmielewski, Jack Aiello, Yelak Biru & Jennifer Ahlstrom lend their voices to the convo! ➡️ FDA ODAC Committee Votes in Favor of Benefit-Risk Profile of Ide-Cel in Early R/R Myeloma onclive.com/view/fda-odac-… via OncLive.com

The IMF knows the value #myeloma support groups offer — that's why we support a network of 160+. Find one near you: myeloma.org/support-groups Thank you @BMSnews for raising awareness during #MyelomaActionMonth

Join us in #SanFrancisco on April 12-13 for a FREE in-person Patient and Family Seminar! Meet the experts and learn about the future of #myeloma, approaches to relapse, new treatments and more. Register: mmsm.link/43nKXpe

Our annual SWOG Cancer Research Network patient advocate picture. I am truly grateful to each one of theses advocates, they have taught me so much. Between us we have years of experience in advocacy with a common goal to improve #clinicaltrials for all. Nothing for the patients without the patients!

FDA Approval Expands Use of Abecma for Multiple Myeloma hematologyadvisor.com/home/topics/my… First Carvykti, now Abecma are both approved for early relapse MM patients. Thank you FDA.

As we go to #ASCO25, #GMAN24, #IMWG, and #EHA24, posting about my coconspirators who helped me become me in the world of myeloma! Jack Aiello Jim Omel #mmsm (Below is us discussing #ClinicalTrial design & implementation at the 2017 International Myeloma Foundation Support Group Leaders Summit)

An important trial for newly diagnosed #Waldenstrom patients.

Suggested approach to 1st relapse of myeloma post #ASCO24 Its suddenly more complicated-and bispecifics will change this too. Bela based triplets >> Dara/Bort/Dex, but CD38+Carfil/Dex still great. Safety of cilta-cel remains in Q, hard to broadly recommend for now. #mmsm

Dr Joseph Mikhael concluding - "The "State" of Myeloma is both great and worrisome. It will take united, international and multidisciplinary patient engaged efforts to overcome myeloma..." #mmsm

## GMANMadrid Day 1: GMAN kicked off w/ global scientific update on myeloma research & latest from the IMF & IMWG! Access to treatment was key focus. Experts discussed innovative approaches like regional Clinical Trials & unique models from Croatia, Denmark, & India. #mmsm

Global collaboration thrives at #IMFGMAN Summit. Yelak Biru Joseph Mikhael Sylviads Myeloma Canada IMFmieloma Myeloma Friends Charitable Trust, India #mmsm #myeloma

The IMF is delighted to honor Dr. Shaji Kumar (Shaji Kumar) with the 2024 Robert A. Kyle Award! His pioneering research has revolutionized myeloma treatment. mmsm.link/4bVnoHF Vincent Rajkumar Brian Durie, M.D. #IMFIMWG #mmsm #myeloma

Congrats Shaji Shaji Kumar! So well deserved! Thank you for all you do for #myeloma patients!

Definitely agree with Jim Omel. Yelak Yelak Biru has already done so much on behalf of #myeloma patients!

Hoping FDA brings back Blenrep for #myeloma pts. Blenrep combination reduced the risk of disease progression or death by nearly 50% versus... - goo.gl/scholar/Qe36BU #ScholarAlerts

Using MRD Status to Deescalate Multiple Myeloma Therapy medpagetoday.com/meetingcoverag… The importance of DECREASING, and even stopping, #mmsm therapy.